You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PSA progressed

Showing 1 - 25 of 2,099
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Disitamab Vedotin（RC48-ADC）
  • (no location specified)
Jul 13, 2023

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Prostate Cancer, Prostate Carcinoma, Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Olaparib)

Recruiting
  • Prostate Cancer
  • +2 more
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Feb 20, 2022

Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

Not yet recruiting
  • Prostate Cancer
  • [177Lu]Lu-PSMA I&T
  • Stereotactic Radiotherapy
  • (no location specified)
May 30, 2023

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,

Active, not recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • Duarte, California
  • +26 more
Aug 3, 2022

Prostate Cancer Trial in London (Nivolumab & Ipilimumab)

Active, not recruiting
  • Prostate Cancer
  • Nivolumab & Ipilimumab
  • London, United Kingdom
    University College London Hospital
Sep 26, 2022

Prostate Cancer Metastatic Trial in United States (ARV-766)

Recruiting
  • Prostate Cancer Metastatic
  • ARV-766 Part A
  • ARV-766 Part B
  • Duarte, California
  • +20 more
Jan 31, 2023

Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
Jan 17, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Phase I and Phase II: LAE001/prednisone + afuresertib
  • Tucson, Arizona
  • +16 more
Nov 30, 2022

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Laboratory Biomarker Analysis
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 19, 2022

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Metastatic Castration Resistant Prostate Cancer Trial in United States (VERU-111)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Golden, Colorado
  • +12 more
Mar 28, 2022

Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-rosopatamb)

Not yet recruiting
  • Metastatic Prostate Cancer
  • 177Lu-DOTA-rosopatamb
  • (no location specified)
Aug 29, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 1, 2022

Prostate Cancer Trial in Canada, Lithuania, United States (No intervention)

Completed
  • Prostate Cancer
  • No intervention
  • Baltimore, Maryland
  • +7 more
Mar 7, 2022

Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 25, 2023

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Rochester (Food

Withdrawn
  • Stage I Prostate Cancer AJCC v8
  • +8 more
  • Food Diary
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 6, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Mobile, Alabama
  • +214 more
Nov 24, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Enzalutamide 40mg
  • +4 more
  • Bellinzona, Switzerland
  • +1 more
Nov 6, 2023

Castration-Resistant Prostatic Tumors Trial in Worldwide (Cetrelimab 480 mg, Apalutamide 240 mg)

Completed
  • Castration-Resistant Prostatic Neoplasms
  • Cetrelimab 480 mg
  • Apalutamide 240 mg
  • San Francisco, California
  • +33 more
Feb 24, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Detroit, Michigan
  • +1 more
Aug 30, 2022

Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

Recruiting
  • Prostate Cancer
  • Brasília, Distrito Federal, Brazil
  • +4 more
Dec 22, 2022

Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)

Completed
  • Metastatic Hormone-Sensitive Prostate Cancer
  • PROSTVAC-V
  • +9 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 3, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022